ZA200406912B - Non-nucleoside reverse transcriptase inhibitors - Google Patents

Non-nucleoside reverse transcriptase inhibitors

Info

Publication number: ZA200406912B
Authority: ZA; South Africa
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; nucleoside; inhibitors
Prior art date: 2002-05-16

Application number

ZA200406912A

Other languages

English (en)

Inventor

Bruno Simoneau

Serge Landry

Eric Malenfant

Julie Naud

Jeffrey O'meara

Bounkham Thavonekham

Christiane Yoakim

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-16

Filing date

2004-08-31

Publication date

2006-06-28

2004-08-31 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2006-06-28 Publication of ZA200406912B publication Critical patent/ZA200406912B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA200406912A 2002-05-16 2004-08-31 Non-nucleoside reverse transcriptase inhibitors ZA200406912B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US38088602P	2002-05-16	2002-05-16

Publications (1)

Publication Number	Publication Date
ZA200406912B true ZA200406912B (en)	2006-06-28

Family

ID=29550032

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200406912A ZA200406912B (en)	2002-05-16	2004-08-31	Non-nucleoside reverse transcriptase inhibitors

Country Status (28)

Country	Link
US (1)	US6806265B2 (fr)
EP (1)	EP1506195B1 (fr)
JP (1)	JP4230448B2 (fr)
KR (1)	KR20050008716A (fr)
CN (1)	CN1318421C (fr)
AR (1)	AR040027A1 (fr)
AT (1)	ATE412653T1 (fr)
AU (1)	AU2003229186A1 (fr)
BR (1)	BR0310033A (fr)
CA (1)	CA2485916C (fr)
DE (1)	DE60324418D1 (fr)
EA (1)	EA009178B1 (fr)
EC (1)	ECSP045432A (fr)
ES (1)	ES2315492T3 (fr)
HR (1)	HRP20041065A2 (fr)
IL (1)	IL163753A0 (fr)
MX (1)	MXPA04010409A (fr)
MY (1)	MY134646A (fr)
NO (1)	NO20044104L (fr)
NZ (1)	NZ536736A (fr)
PE (1)	PE20040365A1 (fr)
PL (1)	PL371663A1 (fr)
RS (1)	RS98004A (fr)
TW (1)	TW200404071A (fr)
UA (1)	UA79285C2 (fr)
UY (1)	UY27809A1 (fr)
WO (1)	WO2003097644A2 (fr)
ZA (1)	ZA200406912B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0302094D0 (en)	2003-01-29	2003-02-26	Pharmagene Lab Ltd	EP4 receptor antagonists
WO2004087169A1 (fr) *	2003-03-27	2004-10-14	Boehringer Ingelheim International Gmbh	Combinaison antivirale de nevirapine et d'un autre compose antiretroviral
WO2005009958A1 (fr)	2003-07-17	2005-02-03	Plexxikon, Inc.	Composes ayant une activite sur des ppar
US7348338B2 (en)	2003-07-17	2008-03-25	Plexxikon, Inc.	PPAR active compounds
GB0324269D0 (en)	2003-10-16	2003-11-19	Pharmagene Lab Ltd	EP4 receptor antagonists
DE102004051277A1 (de) *	2004-10-21	2006-04-27	Merck Patent Gmbh	Heterocyclische Carbonylverbindungen
US7531568B2 (en) *	2004-11-30	2009-05-12	Plexxikon, Inc.	PPAR active compounds
EP1943245A2 (fr) *	2005-09-07	2008-07-16	Plexxikon, Inc.	Dérivés d'indole disubstitué en 1,3 pour utilisation comme composés agissant sur les ppar
TW200800872A (en) *	2005-09-07	2008-01-01	Plexxikon Inc	PPAR active compounds
AU2006287528A1 (en) *	2005-09-07	2007-03-15	Plexxikon, Inc.	1 , 4 and 1 , 5-disubstituted indole derivatives for use as PPAR active compounds
US8492428B2 (en)	2005-09-20	2013-07-23	Mayo Foundation For Medical Education And Research	Small-molecule botulinum toxin inhibitors
PE20090159A1 (es) *	2007-03-08	2009-02-21	Plexxikon Inc	COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
JP2017535573A (ja)	2014-11-25	2017-11-30	バイエルファーマアクチエンゲゼルシャフト	置換されたピリドベンゾジアゼピノン誘導体およびそれの使用
SG11202000217QA (en)	2017-07-21	2020-02-27	Antabio Sas	Chemical compounds
CN112074505B (zh)	2018-03-08	2024-04-05	因赛特公司	作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en)	2018-07-02	2021-06-29	Incyte Corporation	Aminopyrazine derivatives as PI3K-γ inhibitors
CA3229569A1 (fr) *	2021-08-20	2023-02-23	Enanta Pharmaceuticals, Inc.	Inhibiteurs de la 17-beta-hydroxysteroide deshydrogenase de type 13 et leurs procedes d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5366972A (en)	1989-04-20	1994-11-22	Boehringer Ingelheim Pharmaceuticals, Inc.	5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) *	1995-10-06	1998-01-06	Boehringer Ingelheim Pharmaceuticals, Inc.	8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection
TWI270547B (en)	2000-06-16	2007-01-11	Boehringer Ingelheim Ca Ltd	Non-nucleoside reverse transcriptase inhibitors
US6716836B2 (en)	2001-03-22	2004-04-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en)	2001-07-30	2004-01-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors

2003
- 2003-05-06 US US10/430,116 patent/US6806265B2/en not_active Expired - Lifetime
- 2003-05-13 MY MYPI20031796A patent/MY134646A/en unknown
- 2003-05-14 ES ES03724719T patent/ES2315492T3/es not_active Expired - Lifetime
- 2003-05-14 IL IL16375303A patent/IL163753A0/xx unknown
- 2003-05-14 MX MXPA04010409A patent/MXPA04010409A/es active IP Right Grant
- 2003-05-14 AT AT03724719T patent/ATE412653T1/de active
- 2003-05-14 CN CNB038111187A patent/CN1318421C/zh not_active Expired - Fee Related
- 2003-05-14 NZ NZ536736A patent/NZ536736A/en unknown
- 2003-05-14 CA CA002485916A patent/CA2485916C/fr not_active Expired - Fee Related
- 2003-05-14 DE DE60324418T patent/DE60324418D1/de not_active Expired - Lifetime
- 2003-05-14 PL PL03371663A patent/PL371663A1/xx not_active Application Discontinuation
- 2003-05-14 JP JP2004505376A patent/JP4230448B2/ja not_active Expired - Fee Related
- 2003-05-14 AU AU2003229186A patent/AU2003229186A1/en not_active Abandoned
- 2003-05-14 WO PCT/CA2003/000718 patent/WO2003097644A2/fr not_active Ceased
- 2003-05-14 HR HR20041065A patent/HRP20041065A2/hr not_active Application Discontinuation
- 2003-05-14 PE PE2003000461A patent/PE20040365A1/es not_active Application Discontinuation
- 2003-05-14 BR BR0310033-2A patent/BR0310033A/pt not_active IP Right Cessation
- 2003-05-14 KR KR10-2004-7018428A patent/KR20050008716A/ko not_active Withdrawn
- 2003-05-14 EA EA200401482A patent/EA009178B1/ru not_active IP Right Cessation
- 2003-05-14 UA UA20041210291A patent/UA79285C2/uk unknown
- 2003-05-14 RS YU98004A patent/RS98004A/sr unknown
- 2003-05-14 EP EP03724719A patent/EP1506195B1/fr not_active Expired - Lifetime
- 2003-05-15 UY UY27809A patent/UY27809A1/es not_active Application Discontinuation
- 2003-05-15 TW TW092113234A patent/TW200404071A/zh unknown
- 2003-05-16 AR ARP030101708A patent/AR040027A1/es unknown
2004
- 2004-08-31 ZA ZA200406912A patent/ZA200406912B/xx unknown
- 2004-09-27 NO NO20044104A patent/NO20044104L/no unknown
- 2004-11-16 EC EC2004005432A patent/ECSP045432A/es unknown

Also Published As

Publication number	Publication date
ATE412653T1 (de)	2008-11-15
CA2485916C (fr)	2009-12-08
ECSP045432A (es)	2005-01-03
WO2003097644A3 (fr)	2004-02-05
UY27809A1 (es)	2003-12-31
PL371663A1 (en)	2005-06-27
ES2315492T3 (es)	2009-04-01
JP2005526851A (ja)	2005-09-08
JP4230448B2 (ja)	2009-02-25
MXPA04010409A (es)	2005-02-17
CA2485916A1 (fr)	2003-11-27
BR0310033A (pt)	2005-02-15
EA200401482A1 (ru)	2005-06-30
EP1506195A2 (fr)	2005-02-16
RS98004A (sr)	2006-12-15
MY134646A (en)	2007-12-31
US6806265B2 (en)	2004-10-19
EA009178B1 (ru)	2007-12-28
IL163753A0 (en)	2005-12-18
EP1506195B1 (fr)	2008-10-29
CN1318421C (zh)	2007-05-30
AU2003229186A1 (en)	2003-12-02
US20040006071A1 (en)	2004-01-08
NZ536736A (en)	2006-11-30
DE60324418D1 (de)	2008-12-11
NO20044104L (no)	2004-12-01
HK1080849A1 (en)	2006-05-04
TW200404071A (en)	2004-03-16
CN1653066A (zh)	2005-08-10
UA79285C2 (en)	2007-06-11
KR20050008716A (ko)	2005-01-21
WO2003097644A2 (fr)	2003-11-27
AR040027A1 (es)	2005-03-09
HRP20041065A2 (en)	2005-04-30
PE20040365A1 (es)	2004-07-22

Publication	Publication Date	Title
PL378556A1 (pl)	2006-05-02	Nienukleozydowe inhibitory odwrotnej transkryptazy
AU2003269628A1 (en)	2004-04-08	Non-nucleoside reverse transcriptase inhibitors
EG25482A (en)	2012-01-15	Inhibitors
PL373649A1 (en)	2005-09-05	Kinase inhibitors
SI1569907T1 (sl)	2016-06-30	Na nikotinamidu osnovani kinazni inhibitorji
AU2003271566A8 (en)	2004-03-03	Pyrrolopyrazines as kinase inhibitors
IL144349A0 (en)	2002-05-23	Non-nucleoside reverse transcriptase inhibitors
TWI372619B (en)	2012-09-21	Non-nucleoside reverse transcriptase inhibitors
EP1558609A4 (fr)	2008-05-28	Inhibiteurs de kinase
IL163753A0 (en)	2005-12-18	Non-nucleoside reverse transcriptase inhibitors
EP1532133A4 (fr)	2006-11-15	Inhibiteurs de nf-:b
EP1569907A4 (fr)	2007-10-31	Inhibiteurs de kinase a base de nicotinamide
AU7037001A (en)	2001-12-24	Non-nucleoside reverse transcriptase inhibitors
IL157543A (en)	2010-11-30	Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
EP1541580A4 (fr)	2010-05-19	Inhibiteurs de sulfotransferase
HRP20040886A2 (en)	2005-06-30	Non-nucleoside reverse transcriptase inhibitors
EP1326640A4 (fr)	2004-12-15	Therapie antiretrovirale a base d'inhibiteurs de la transcriptase inverse
AU2003232362A8 (en)	2003-12-22	4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2002355614A1 (en)	2003-02-17	Non-nucleoside reverse transcriptase inhibitors
SI1294720T1 (sl)	2006-08-31	Nenukleozidni inhibitorji reverzne transkriptaze
HK1073113A (zh)	2005-09-23	非核苷逆转录酶抑制剂
DK1373267T3 (da)	2005-03-29	Non-nucleoside revers transkriptase-inhibitorer
GB0226149D0 (en)	2002-12-18	Inhibitors
GB0224102D0 (en)	2002-11-27	Inhibitors
GB0217330D0 (en)	2002-09-04	Inhibitors